Patents by Inventor Daniel Louis Kacian

Daniel Louis Kacian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6214587
    Abstract: Methods for amplifying target nucleic acid sequences using a nucleic acid polymerase lacking 5′ exonuclease activity and a set of oligonucleotide primers. Preferably, a primer array is used. The primer array contains two sets of primers. One set contains at least two complementary primers. The other set contains at least two sense primers. Using the described methods amplification can be carried out under essentially constant environmental conditions without the requirement for exonuclease activity or restriction endonuclease activity.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: April 10, 2001
    Assignee: Gen-Probe Incorporated
    Inventors: Nanibhushan Dattagupta, Paul Douglas Stull, Marc Spingola, Daniel Louis Kacian
  • Patent number: 6087133
    Abstract: Methods for amplifying target nucleic acid sequences using a nucleic acid polymerase lacking 5' exonuclease activity and a set of oligonucleotide primers. Preferably, a primer array is used. The primer array contains two sets of primers. One set contains at least two complementary primers. The other set contains at least two sense primers. Using the described methods amplification can be carried out under essentially constant environmental conditions without the requirement for exonuclease activity or restriction endonuclease activity.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: July 11, 2000
    Assignee: Gen-Probe Incorporated
    Inventors: Nanibhushan Dattagupta, Paul Douglas Stull, Marc Spingola, Daniel Louis Kacian
  • Patent number: 5998195
    Abstract: A plasmid for expression of Moloney Murine Leukemia Virus-derived reverse transcriptase in E. coli cells deficient in the expression of indiginous RNAse activity, a method for purification of the recombinant enzyme, and a composition comprising a cloned and purified reverse transcriptase opimized for use in cDNA and nucleic acid amplification procedures.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: December 7, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Michael Garth Riggs, James Garfield Putnam
  • Patent number: 5935833
    Abstract: A plasmid for expression of Moloney Murine Leukemia Virus-derived reverse transcriptase in E. coli cells deficient in the expression of indiginous RNAse activity, a method for purification of the recombinant enzyme, and a composition comprising a cloned and purified reverse transcriptase opimized for use in cDNA and nucleic acid amplification procedures.
    Type: Grant
    Filed: January 9, 1997
    Date of Patent: August 10, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Michael Garth Riggs, James Putnam
  • Patent number: 5916777
    Abstract: The present invention relates to methods of enzymatically synthesizing oligonucleotides. In particular, it relates to the use of 3'-ribonucleotide primers which effectively serve to initiate oligonucleotide synthesis, and can also be easily cleaved from synthesis products and reused in subsequent synthesis reactions.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: June 29, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Nanibhushan Dattagupta, David Bruce Lackey
  • Patent number: 5888779
    Abstract: Kits for synthesizing multiple copies of a target nucleic acid sequence autocatalytically under conditions of substantially constant temperature, ionic strength, and pH are provided in which multiple RNA copies of the target sequence autocatalytically generate additional copies. These methods are useful for generating copies of a nucleic acid target sequence for purposes which include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 30, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Timothy J. Fultz
  • Patent number: 5871975
    Abstract: Methods and kits for the use of a non-ionic detergent to suppress enzyme inhibition in a reaction solution due to the presence of inhibiting ionic detergent. Prior to reaction, the reaction mixure is given an effective amount of a non-ionic detergent, and agitated. The enzyme is then added, and the enzymatic reaction is the allowed to proceed. Also disclosed are preferred embodiments of the present invention, and kits for nucleic acid amplification of a biological sample in the presence of an ionic detergent.
    Type: Grant
    Filed: March 25, 1997
    Date of Patent: February 16, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Diane Lisa McAllister
  • Patent number: 5846701
    Abstract: Methods and kits for the use of a non-ionic detergent to suppress enzyme inhibition in a reaction solution due to the presence of inhibiting ionic detergent. Prior to reaction, the reaction mixture is given an effective amount of a non-ionic detergent, and agitated. The enzyme is then added, and the enzymatic reaction is the allowed to proceed. Also disclosed are preferred embodiments of the present invention, and kits for nucleic acid amplification of a biological sample in the presence of an ionic detergent.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: December 8, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Diane Lisa McAllister
  • Patent number: 5834254
    Abstract: Stabilized enzyme compositions for use in nucleic acid amplification. Compositions are provided for the stabilization of one or more enzymes in a single stabilized formulation. Additional compositions incorporate a dried, stabilized enzyme mixture together with necessary cofactors and enzyme substrates in a single container for use upon rehydration. Also disclosed are methods for making and using stabilized enzyme compositions and kits for nucleic acid amplification incorporating the disclosed compositions.
    Type: Grant
    Filed: July 22, 1997
    Date of Patent: November 10, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Nancy Lau Liu Shen, Daniel Louis Kacian, James Garfield Putnam, William Michael Davis
  • Patent number: 5824518
    Abstract: Methods of synthesizing multiple copies of a target nucleic acid sequence autocatalytically under conditions of substantially constant temperature, ionic strength, and pH are provided in which multiple RNA copies of the target sequence autocatalytically generate additional copies. These methods are useful for generating copies of a nucleic acid target sequence for purposes which include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 20, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Timothy J. Fultz
  • Patent number: 5766890
    Abstract: Methods and kits for the use of a non-ionic detergent to suppress enzyme inhibition in a reaction solution due to the presence of inhibiting ionic detergent. Prior to reaction, the reaction mixture is given an effective amount of a non-ionic detergent, and agitated. The enzyme is then added, and the enzymatic reaction is the allowed to proceed. Also disclosed are preferred embodiments of the present invention, and kits for nucleic acid amplification of a biological sample in the presence of an ionic detergent.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: June 16, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Daniel Louis Kacian, Diane Lisa McAllister
  • Patent number: 5739311
    Abstract: The present invention relates to methods of synthesizing phosphorothioate oligonucleotides. In particular, it relates to the use of certain restriction endonucleases to cleave phosphorothioate oligonucleotides which contain restriction endonuclease recognition sequences. These restriction sequences facilitate the cleavage of relatively cleavage resistant phosphorothioate oligonucleotides thus facilitating their separation and purification after synthesis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 14, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: David Bruce Lackey, Nanibhushan Dattagupta, Daniel Louis Kacian
  • Patent number: 5710029
    Abstract: Methods and kits for relating initial amounts of target nucleic acids present in a sample to target-specific amplification products. It has been discovered that the transcription-mediated amplification system is capable of producing a quantitative relationship between target input and target-specific output. Further, the present invention relates to methods for carefully controlling this relationship resulting in an unexpectedly high degree of reproducability. Also described are useful methods for extending the dynamic range of transcription-based amplification systems.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 20, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Thomas Brendan Ryder, Karen W. Shannon, Daniel Louis Kacian, Richard C. Harvey, Sherrol H. McDonough, Frank R. Gonzales, Maria R. Castillo, Elizabeth R. Billyard, Nancy Lau Liu Shen
  • Patent number: 5705365
    Abstract: Methods and kits for relating initial amounts of target nucleic acids present in a sample to target-specific amplification products. It has been discovered that the transcription-mediated amplification system is capable of producing a quantitative relationship between target input and target-specific output. Further, the the present invention relates to methods for carefully controlling this relationship resulting in an unexpectedly high degree of reproducability. Also described are useful methods for extending the dynamic range of transcription-based amplification systems.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 6, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Thomas Brendan Ryder, Karen W. Shannon, Daniel Louis Kacian, Richard C. Harvey, Sherrol H. McDonough, Frank R. Gonzales, Maria R. Castillo, Elizabeth R. Billyard, Nancy Lau Liu Shen
  • Patent number: 5652126
    Abstract: The present invention relates to methods of cleaving phosphorothioate oligonucleotides. In particular, it relates to the use of certain restriction endonucleases to cleave phosphorothioate oligonucleotides which contain restriction endonuclease recognition sequences. These restriction sequences can be used to facilitate the cleavage of relatively cleavage resistant phosphorothioate oligonucleotides thus facilitating their separation and purification after synthesis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 29, 1997
    Assignee: Gen-Probe Incorporated
    Inventors: David Bruce Lackey, Nanibhushan Dattagupta, Daniel Louis Kacian
  • Patent number: RE38960
    Abstract: Methods for amplifying target nucleic acid sequences using a nucleic acid polymerase lacking 5? exonuclease activity and a set of oligonucleotide primers. Preferably, a primer array is used. The primer array contains two sets of primers. One set contains at least two complementary primers. The other set contains at least two sense primers. Using the described methods amplification can be carried out under essentially constant environmental conditions without the requirement for exonuclease activity or restriction endonuclease activity.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: January 31, 2006
    Assignee: Gen-Probe Incorporated
    Inventors: Nanibhushan Dattagupta, Paul Douglas Stull, Marc Spingola, Daniel Louis Kacian
  • Patent number: RE39007
    Abstract: Methods for amplifying target nucleic acid sequences using a nucleic acid polymerase lacking 5? exonuclease activity and a set of oligonucleotide primers. Preferably, a primer array is used. The primer array contains two sets of primers. One set contains at least two complementary primers. The other set contains at least two sense primers. Using the described methods amplification can be carried out under essentially constant environmental conditions without the requirement for exonuclease activity or restriction endonu- clease activity.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: March 7, 2006
    Assignee: Gen-Probe Incorporated
    Inventors: Nanibhushan Dattagupta, Paul Douglas Stull, Marc Spingola, Daniel Louis Kacian